Skip to main content

EDITORIAL article

Front. Nutr., 13 January 2022
Sec. Nutrition and Microbes
This article is part of the Research Topic Gut Microbial Response to Host Metabolic Phenotypes: Volume 1 View all 24 articles

Editorial: Gut Microbial Response to Host Metabolic Phenotypes

  • 1College of Animal Science and Technology, Hunan Agricultural University, Changsha, China
  • 2College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, China
  • 3State Key Laboratory of Animal Nutrition, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, China

Editorial on the Research Topic
Gut Microbial Response to Host Metabolic Phenotypes

It is increasingly apparent that gut microbiota perform functions crucial to the host, such as regulating host physiology and influencing host health (13). Using fecal bacteria transplantation technology, Wu et al. found that fecal microbiota from obese Jinhua pigs and lean Landrace pigs exert different lipid metabolic phenotypes. Zheng et al. also witnessed gut microbial alterations in high fat diet-fed mice, with a high ratio of Firmicutes to Bacteroidetes and abundance of Allobaculum. Although this Research Topic failed to receive any papers about the role of gut microbiota in amino acid metabolism, nucleic acid metabolism, and carbohydrate metabolism, other reports have confirmed these functions (4, 5).

Currently, the gut microbiota is attracting much interest due to its role in maintaining host health and its association with all aspects of health and diseases. In this Research Topic, gut microbial disorders are screened in persistent atrial fibrillation patients (Xu et al.) renal cell carcinoma metastasis patients (Dai et al.), and a spinal cord injury animal model (Rong et al.). Xu et al. thoroughly discussed the taxonomic and functional characteristics of the gastrointestinal microbiota and demonstrated the profound relationship between gastrointestinal microbiota and metabolic disorders in ruminants. Together, these results further confirmed the role of gut microbiota in disease occurrence and development and manipulation of gut microbiota might, therefore, be considered a potential target for treating diseases.

Indeed, various disease treatment measures include gut microbial improvement, such as dietary probiotics (6). For example, Zhang et al. reported that dietary Lactobacillus acidophilus ATCC 4356 improved gut microbiota distribution and alleviated renal ischemia–reperfusion injury. Similarly, beneficial effects of Lactobacillus have been identified in lumbar disc herniation (Wang et al.), hypercholesterolemic golden hamsters (Yang et al.), asthma, and Clostridium perfringens infection (Wang et al.). In animal production, the gut is generally disturbed by weaning stress, dietary toxins, and pathogen infections, thus dietary probiotics have been widely introduced to maintain a healthy gut and guarantee higher production performance (7). Lactococcus lactis, in this Research Topic, has been identified to improve gut function in piglets (Yu et al.). However, probiotics are not limited to Lactobacillus, some species of Bifidobacterium, Escherichia coli, Enterococcus, and Saccharomyces have long been used as probiotics to alleviate various diseases by changing gut microbiota compositions.

Gut microbiota diversity and compositions are highly associated with dietary fluctuations. Thus, dietary manipulation has also been used to target gut microbiota to regulate host physiology and metabolism. In this Research Topic, Qian et al. found that dietary dried citrus peel (Chenpi) improved gut microbiota compositions in high fat diet-fed mice. Li et al. concluded that maternal fiber nutrition during pregnancy regulated the health of offspring, and the response of the maternal intestinal microbes played an important role in intervening in the phenotype of sows and neonatal piglets. Dietary protein and amino acids are the main factors shaping gut microbiota (8), Fu et al. also reported a role of tryptophan in gut microbiota. Besides, vitamin K2 (Liu et al.), β-carotene (Yuan et al.), olive fruit extracts (Wang et al.), bovine lactoferrin (Wang et al.), and β-sitosterol (Yu et al.) have been reported to shape gut microbiota compositions in this Research Topic.

How does gut microbiota affect host physiology and metabolism? Hou et al. showed that the gut–liver FXR–FGF19 axis is involved in Lactobacillus delbrueckii-promoted ileal bile acid deconjugation. In our previous studies, we found that gut microbiota-derived metabolites are highly associated with host metabolic reprograming (912). Furthermore, bacterial microRNA, bacteriocin, and microbiota sensing pathways have also been identified to be involved in the relationship between gut microbiota and host metabolism (13, 14). However, with the focus on the detailed mechanism by which gut microbiota influence host metabolism, much still needs to be elucidated.

In summary, papers from the current Research Topic screened the gut microbiota dysbiosis in various diseases and reported the beneficial roles of dietary probiotics and other active components in the improvement of gut microbiota. Despite the progress made in understanding the relationship between gut microbiota and host metabolism, there are a number of prominent research avenues that remain to be explored. For example, what are the molecular and physiological links between the gut microbiota and host metabolism at the epigenetic, transcriptome, and proteome levels? Gut microbiota is changed in various pathologic conditions and microbial biomarkers need to be screened in specific metabolic diseases. Additionally, dietary manipulation is widely used to maintain a healthy gut microbiota composition, and the interaction between diets, gut microbiota, and host metabolism will be an important area of future research.

Author Contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Funding

This study was supported by the National Natural Science Foundation of China (32172761) and the Young Elite Scientists Sponsorship Program by CAST (2019-2021QNRC001).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We would like to thank all authors for their papers and the reviewers for the painstaking care taken in helping improve the clarity of the manuscript.

References

1. Yin J, Li YY, Han H, Ma J, Liu G, Wu X, et al. Administration of exogenous melatonin improves the diurnal rhythms of the gut microbiota in mice fed a high-fat diet. mSystems. (2020) 5:e00002-20. doi: 10.1128/mSystems.00002-20

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Tian M, Chen JM, Liu JX, Chen F, Guan WT, Zhang HS. Dietary fiber and microbiota interaction regulates sow metabolism and reproductive performance. Anim Nutr. (2020) 6:397–403. doi: 10.1016/j.aninu.2020.10.001

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Ma J, Zheng YM, Tang WJ, Yan WX, Nie HF, Fang J, et al. Dietary polyphenols in lipid metabolism: a role of gut microbiome. Anim Nutr. (2020) 6:404–9. doi: 10.1016/j.aninu.2020.08.002

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. (2018) 23:716–24. doi: 10.1016/j.chom.2018.05.003

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. (2021) 19:55–71. doi: 10.1038/s41579-020-0433-9

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Azad MAK, Gao J, Ma J, Li TJ, Tan B, Huang XG, et al. Opportunities of prebiotics for the intestinal health of monogastric animals. Anim Nutr. (2020) 6:379–88. doi: 10.1016/j.aninu.2020.08.001

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Azad MAK, Sarker M, Li T, Yin J. Probiotic species in the modulation of gut microbiota: an overview. Biomed Res Int. (2018) 2018:9478630. doi: 10.1155/2018/9478630

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Yin J, Ma J, Li YY, Ma XK, Chen JS, Zhang HH, et al. Branched-chain amino acids, especially of leucine and valine, mediate the protein restricted response in a piglet model. Food Funct. (2020) 11:1304–11. doi: 10.1039/C9FO01757G

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Yin J, Li YY, Han H, Chen S, Gao J, Liu G, et al. Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high-fat diet-fed mice. J Pineal Res. (2018) 65:e12524. doi: 10.1111/jpi.12524

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Duan YH, Zhong YZ, Xiao H, Zheng CB, Song B, Wang WL, et al. Gut microbiota mediates the protective effects of dietary beta-hydroxy-beta-methylbutyrate (HMB) against obesity induced by high-fat diets. Faseb J. (2019) 33:10019–33. doi: 10.1096/fj.201900665RR

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Han H, Yi B, Zhong R, Wang M, Zhang S, Ma J, et al. From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators. Microbiome. (2021) 9:162. doi: 10.1186/s40168-021-01093-y

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Han H, Jiang Y, Wang M, Melaku M, Liu L, Zhao Y, et al. Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut-liver axis. Crit Rev Food Sci Nutr. (2021) 18:1–18. doi: 10.1080/10408398.2021.1966738

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. (2012) 336:1262–7. doi: 10.1126/science.1223813

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Visconti A, Le Roy CI, Rosa F, Rossi N, Martin TC, Mohney RP, et al. Interplay between the human gut microbiome and host metabolism. Nat Commun. (2019) 10:4505. doi: 10.1038/s41467-019-12476-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: gut microbiota, metabolism, disease, probiotics, diets

Citation: Yin J, Su Y and Han H (2022) Editorial: Gut Microbial Response to Host Metabolic Phenotypes. Front. Nutr. 8:817501. doi: 10.3389/fnut.2021.817501

Received: 18 November 2021; Accepted: 13 December 2021;
Published: 13 January 2022.

Edited and reviewed by: Christophe Lacroix, ETH Zürich, Switzerland

Copyright © 2022 Yin, Su and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yong Su, yong.su@njau.edu.cn; Hui Han, hanhui16@mails.ucas.ac.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.